Navigation Links
Hoya Announces Second Quarter and First Half Financial Results for FY2008
Date:11/10/2008

TOKYO, November 10 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the second quarter ended September 30, 2008. Net sales were 128.3 billion yen for the quarter, representing an increase of 27.1% from 100.9 billion yen in the second quarter of 2007 mainly reflecting the additional results of PENTAX included in the scope of consolidation during the previous fiscal year.

Operating income was 20.6 billion yen, a 23.2% decrease compared with 26.8 billion yen in the second quarter of 2007, due mainly to order decrease and the drop in the product price in global economic downturn. Net income for the second quarter was 19.1 billion yen, a 9.0% decrease compared with 21.0 billion yen in the same period of 2007. Earnings per share for the quarter were 44.21 yen compared with 48.64 yen in the second quarter of 2007.

For the first six months ending September 30, 2008, net sales were 258.5 billion yen, a 30.1% growth compared with 198.7 billion yen in the same period of 2007. Operating income was 42.4 billion yen, a 14.2% decrease compared with 49.4 billion yen in the first half of 2007, while net income was 40.3 billion yen, a 5.8% increase compared with 38.1 billion yen in the same period of 2007. Earnings per share were 93.18 yen compared with 88.25 yen in the first half of 2007.

"Shrinkage of the semiconductor market and severe price competition in overall business fields continues to have a negative impact on our second quarter 2008," said Hiroshi Hamada, chief operating officer of HOYA. "The market will continue to be weak, however, we will promote expansion of our growth areas including eyeglass business, endoscopic system and contact lens retail business."

The full quarterly report is available in "Financial Statement" page in HOYA website Investor Relations section at: http://www.hoya.co.jp/english/

*Results are preliminary and unaudited.

*The yen amounts shown therein are rounded down to the nearest 100 million.

About Hoya Corporation

Hoya Corporation is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: Information Technology makes mask blanks and photomasks for the semiconductor devices and LCD panels, optical lenses for digital cameras, and glass memory disks for HDDs. The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surgery. The Life Care provides endoscopic system. The Imaging produces SLR/compact digital cameras, interchangeable lenses, lens modules and microlenses. Hoya now has over 100 subsidiaries and affiliates, and employs approximately 38,000 people worldwide.

Contact Information:

Akiko Maeyama / Naoji Ito

Corporate Communications

Hoya Group

Tel: +81-3-3232-0065

E-mail: HOYA-pr@mb.hoya.co.jp


'/>"/>
SOURCE Hoya Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. WaferGen Announces Third Quarter 2008 Financial Results
2. ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes
3. Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc.
4. WellSpring Pharmaceutical Corp. Announces Hire of Wayne Miller as Vice President, Sales & Marketing, Consumer Brands
5. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
6. BIO-key(R) Announces Third Quarter 2008 Earnings Release and Conference Call Schedule
7. BioMS Medical Announces Third Quarter 2008 Results
8. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
9. deCODE genetics Announces Third Quarter 2008 Financial Results
10. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
11. Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... Leaders of Quorum Review IRB and ... sessions at this week’s Association of Clinical Research Professionals (ACRP) 2017 Meeting & ... research. , "We are excited to present subject matter expertise on topics that impact ...
(Date:4/21/2017)... TX (PRWEB) , ... April 21, 2017 , ... Having ... than a year, Formaspace is pleased to introduce it to top lab design architects ... Formaspace CEO Jeff Turk and VP of Industrial Design and Engineering Greg Casey will ...
(Date:4/21/2017)... ... , ... Frederick Innovative Technology Center, Inc. (FITCI), a business ... start-ups, is hosting “Celebration Friday” (a festive gathering highlighting client success stories) and ... networking at 3:30 p.m. at FITCI’s 4539 Metropolitan Court location, off English Muffin ...
(Date:4/20/2017)... , April 20, 2017  Eli Lilly and Company ... data evaluating galcanezumab for the prevention of migraine at ... will take place April 22-28, 2017, in ... four abstracts at AAN, including safety and patient outcomes ... associated with a reduction in monthly migraine headache days ...
Breaking Biology Technology:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
Breaking Biology News(10 mins):